Dr Rouchelle Srinanjan-Rothwell, NIHR clinical lecturer at the University of Cambridge, talks about her recently published IVORY trial, in which the Cambridge team investigated anti-inflammatory therapy using repurposed IL-2 drug to treat acute coronary syndromes

You can find the study here: Anti-inflammatory therapy with low-dose IL-2 in acute coronary syndromes: a randomized phase 2 trial | Nature Medicine

In this episode, we also hear from Mark Andrews, recently treated at CUH for a heart attack, and who took part in the trial.

Let us know what you would like to hear from next by commenting!

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Dr Ahsen Ustaoglu. Innehållet i podden är skapat av Dr Ahsen Ustaoglu och inte av, eller tillsammans med, Poddtoppen.